Business Context and Reporting Period
Company: Chemed Corporation (CHEMED CORP)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2006
Headquarters: Cincinnati, Ohio
Chemed Corporation operates through two primary segments: the Vitas Group, the nation's largest provider of hospice services, and the Roto-Rooter Group, a provider of sewer, drain, and pipe cleaning services. The Company is a large accelerated filer with stock traded on the New York Stock Exchange. As of December 31, 2006, the Company employed 11,621 individuals.
Key Financial Metrics
Note: Specific consolidated revenue, net income, and cash flow figures for 2006 are incorporated by reference to the 2006 Annual Report to Stockholders and are not explicitly detailed in the provided text. The following metrics are derived from the text:
- Debt and Liquidity: The Company repaid $84.6 million of debt in 2006. As of December 31, 2006, the Company had no variable rate debt outstanding. The carrying value of long-term debt was approximately $150.5 million, with a market value of approximately $155.0 million.
- Stock Performance: The stock price ranged from a high of $61.28 to a low of $29.99 in 2006. Dividends paid were $0.06 per share for each quarter.
- Share Repurchases: The Company repurchased 240,182 shares in 2006 under two programs (February 2000 and July 2006 programs). Approximately $42.9 million remained authorized under the July 2006 program.
- Equity Compensation: As of December 31, 2006, there were 1,660,522 securities to be issued upon exercise of outstanding options with a weighted-average exercise price of $30.53.
- Environmental Liabilities: The accrual for estimated environmental cleanup costs related to the former DuBois Chemicals Inc. was $3.5 million ($2.6 million current, $0.9 million long-term). A contingent liability of up to $14.9 million exists but is not recorded as payment is not considered probable.
Material Changes and Unusual Items
- Debt Reduction: Significant debt repayment of $84.6 million occurred during 2006.
- Legal Settlements:
- Roto-Rooter Litigation: A class action lawsuit regarding unlicensed plumbing work in Illinois was settled. The Company accrued $3.1 million in 2004, and the court approved the settlement in July 2006.
- Vitas Wage and Hour Litigation: A class action lawsuit regarding overtime and meal/break violations in California (Costa case) was settled for $19 million (inclusive of fees and costs). Final court approval was granted on June 26, 2006.
- Patient Care Sale Settlement: Litigation regarding the 2002 sale of the Patient Care subsidiary was settled in October 2006. The Company agreed to forgive $1.2 million in valuation adjustments and recorded a pretax impairment charge of $1.4 million related to a warrant.
- Regulatory Investigation: The Office of Inspector General (OIG) served civil subpoenas in 2005 regarding alleged billing failures. The Company recorded pretax expenses of $1.068 million for the twelve months ended December 31, 2006, related to defending this matter.
- Seasonality: Roto-Rooter results are impacted by fourth-quarter advertising costs. In Q4 2006, $6.6 million (32% of full-year costs) was expensed for telephone directory advertising.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The Company does not provide specific numerical guidance in this text but notes that future dividends depend on earnings, financial condition, and debt covenants. Management believes its hospices are in material compliance with regulatory requirements, though it acknowledges the risk of future payment reductions or recoupments from Medicare/Medicaid.
Key Risks and Contingencies:
- Government Reimbursement (Vitas): Over 90% of Vitas revenue comes from Medicare and Medicaid. Profitability is highly sensitive to reimbursement rates, which may not keep pace with inflation. Two Vitas facilities exceeded the Medicare hospice cap in 2006, potentially leading to future payment reductions.
- Regulatory and Legal: The Company faces ongoing risks from the OIG investigation and a pending qui tam lawsuit. There is also a new class action lawsuit filed in September 2006 (Santos case) alleging similar wage and hour violations in California; liability is currently unestimable.
- Debt Covenants: Indebtedness restricts the Company's ability to incur additional debt, pay dividends, or make acquisitions. A default could accelerate repayment obligations.
- Competition and Labor: Vitas faces a nationwide shortage of qualified nurses, driving up wage costs. Roto-Rooter operates in a highly fragmented and competitive market.
- Environmental: Potential additional environmental liabilities from the DuBois Chemicals sale could reach $14.9 million, though management does not currently expect these to be paid.
Investor Verification Checklist
- Consolidated Financial Statements: Verify total revenue, net income, and operating cash flow for 2006 in the full Annual Report to Stockholders (incorporated by reference).
- Medicare Cap Impact: Confirm the financial impact of the two Vitas facilities exceeding the Medicare hospice cap in 2006 and any subsequent recoupments.
- Legal Exposure: Monitor the status of the pending OIG investigation and the new "Santos" class action lawsuit for potential additional liabilities beyond the $19 million Costa settlement.
- Debt Structure: Review the specific terms of the $150.5 million long-term debt and the impact of the $84.6 million repayment on future liquidity and covenant compliance.
- Environmental Reserve: Assess the adequacy of the $3.5 million environmental reserve against the potential $14.9 million contingent liability from the DuBois Chemicals sale.